Page last updated: 2024-10-27

gemfibrozil and Menopause

gemfibrozil has been researched along with Menopause in 1 studies

Menopause: The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age.

Research Excerpts

ExcerptRelevanceReference
"We compared the efficacy of three formulations and two dosage regimens of gemfibrozil in 322 dyslipidemic (non-high-density lipoprotein [HDL] cholesterol level, greater than or equal to 5."2.67Gemfibrozil also corrects dyslipidemia in postmenopausal women and smokers. ( Koskinen, P; Kovanen, PT; Manninen, V; Tuomilehto, J, 1992)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koskinen, P1
Kovanen, PT1
Tuomilehto, J1
Manninen, V1

Trials

1 trial available for gemfibrozil and Menopause

ArticleYear
Gemfibrozil also corrects dyslipidemia in postmenopausal women and smokers.
    Archives of internal medicine, 1992, Volume: 152, Issue:1

    Topics: Apolipoproteins B; Chemistry, Pharmaceutical; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Drug

1992